Treatment for Triple Negative Breast Cancer: An Update
July 20, 2010
Presented by Melinda Telli, MD.; Acting Assistant Professor; Division of Oncology; Stanford University School of Medicine; Stanford, CA. This session focuses on specific groups of women who are likely to develop TNBC; features of TNBC that make it unique and challenging to treat; and emerging and promising treatment options for TNBC.
People concerned about hereditary cancer, cancer survivors, previvors, and health care providers.